05.10.2021 • News

Synthos to Build Butadiene Plant at Plock

Polish plastics and rubber producer Synthos is building a new butadiene extrusion unit, coupled with associated logistics infrastructure, at Plock, Poland. The new facility due on stream in 2024 will have an ultimate capacity of 120,000 t/y and will feed the company’s production in central and eastern Europe.

Air Liquide Engineering and Construction, the plant contracting arm of the French industrial gases group, will handle overall engineering, procurement and construction services as well as providing BASF’s NMP butadiene extraction technology under license.

The new Polish BD unit, the first for Synthos at Plock, will triple output capability for the chemical at the site, where around 50,000 t/y is already produced downstream of the PKN Orlen cracker. The company based at Oswiecim, Poland, plans to use the additional output volume mainly to feed its styrene-butadiene-rubber (SBR) plant and a 50,000 t/y polystyrene plant at its headquarters site 350 km to the south.

In May of this year, Synthos inked a deal with Trinseo to acquire the US styrenics and rubber producer’s Schkopau, Germany-based synthetic rubber business for $491 million. The transaction, which is set to close late this year or early next year, encompasses the East German assets bought by Dow Chemical in the mid-1990s from the German state-owned Treuhandanstalt, the agency that wound up the production assets of the former German Democratic Republic.

Author: Dede Williams, Freelance Journalist

Polish plastics and rubber producer Synthos is building a new butadiene...
Polish plastics and rubber producer Synthos is building a new butadiene extrusion unit and associated logistics infrastructure at Plock, Poland. The new 120,000 t/y facility due on stream in 2024 will feed the company’s production in central and eastern Europe. (c) Synthos

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

most read